|
TPST1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.001500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.786100E-04 |
| Normal-vs-Stage2 |
7.368300E-04 |
| Normal-vs-Stage3 |
2.106000E-02 |
| Normal-vs-Stage4 |
7.645600E-02 |
| Stage1-vs-Stage2 |
4.466200E-01 |
| Stage1-vs-Stage3 |
5.557400E-01 |
| Stage1-vs-Stage4 |
8.187000E-01 |
| Stage2-vs-Stage3 |
3.113000E-01 |
| Stage2-vs-Stage4 |
4.982000E-01 |
| Stage3-vs-Stage4 |
8.899200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.363600E-04 |
| Normal-vs-AfricanAmerican |
3.097600E-03 |
| Normal-vs-Asian |
4.792400E-01 |
| Caucasian-vs-AfricanAmerican |
9.893000E-01 |
| Caucasian-vs-Asian |
4.653600E-01 |
| AfricanAmerican-vs-Asian |
4.665800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14399999999282E-05 |
| Normal-vs-Female |
1.257430E-01 |
| Male-vs-Female |
1.116320E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.256200E-03 |
| Normal-vs-Extreme_Weight |
1.141690E-03 |
| Normal-vs-Obese |
1.679020E-03 |
| Normal-vs-Extreme_Obese |
1.021950E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.103000E-01 |
| Normal_Weight-vs-Obese |
6.693800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.798000E-01 |
| Extreme_Weight-vs-Obese |
7.119800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.959200E-01 |
| Obese-vs-Extreme_Obese |
2.480000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.824850E-01 |
| Normal-vs-Age(41-60Yrs) |
1.551970E-02 |
| Normal-vs-Age(61-80Yrs) |
5.79339999999817E-05 |
| Normal-vs-Age(81-100Yrs) |
1.215900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.713800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.202180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.504200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.121900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.292230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.713000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.500400E-03 |
| Normal-VS-Type2 PRCC |
2.3729000000472E-06 |
| Normal-VS-KIRP CIMP |
2.030400E-01 |
| Normal-VS-Unclassified PRCC |
1.317160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.444600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.555800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.679200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.925600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.684200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.433000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.648700E-04 |
| Normal-vs-N1 |
1.308160E-01 |
| Normal-vs-N2 |
9.342200E-01 |
| N0-vs-N1 |
1.385600E-01 |
| N0-vs-N2 |
2.609900E-02 |
| N1-vs-N2 |
4.052200E-01 |
|
|
